| |
 |
|
Class Information
Number: 536/24.5
Name: Organic compounds -- part of the class 532-570 series > Organic compounds (class 532, subclass 1) > Carbohydrates or derivatives > Nitrogen containing > N-glycosides, polymers thereof, metal derivatives (e.g., nucleic acids, oligonucleotides, etc.) > Dna or rna fragments or modified forms thereof (e.g., genes, etc.) > Nucleic acid expression inhibitors
Description: Fragments of DNA or RNA which are effective inhibitors of transcription or translation.
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7612196 |
siRNA targeting cyclin-dependent kinase inhibitor 1B (p27, Kip1) (CDKN1B) |
Nov. 3, 2009 |
| 7612195 |
Retroviral vectors for delivery of interfering RNA |
Nov. 3, 2009 |
| 7612194 |
Nucleic acid sequences from Diabrotica virgifera virgifera LeConte and uses thereof |
Nov. 3, 2009 |
| 7612185 |
Nucleic acid biosensors |
Nov. 3, 2009 |
| 7611723 |
Stinging cells expressing an exogenous polynucleotide encoding a therapeutic, diagnostic or a cosmetic agent and methods compositions and devices utilizing such stinging cells or capsules deri |
Nov. 3, 2009 |
| 7608707 |
siRNA targeting survivin |
Oct. 27, 2009 |
| 7608706 |
siRNA targeting ras-related nuclear protein |
Oct. 27, 2009 |
| 7608705 |
Oligonucleotides, agents containing these oligonucleotides, and the use thereof |
Oct. 27, 2009 |
| 7608698 |
Hypoxia inducible factors and uses thereof for inducing angiogenesis and improving muscular functions |
Oct. 27, 2009 |
| 7605252 |
siRNA targeting kinase insert domain receptor (KDR) |
Oct. 20, 2009 |
| 7605251 |
Compositions and methods for inhibiting expression of the PCSK9 gene |
Oct. 20, 2009 |
| 7605250 |
siRNA targeting cAMP-specific phosphodiesterase 4D |
Oct. 20, 2009 |
| 7605249 |
Treatment of neurodegenerative disease through intracranial delivery of siRNA |
Oct. 20, 2009 |
| 7604977 |
Methods and compositions for inhibiting HIV infection |
Oct. 20, 2009 |
| 7601700 |
Modulation of eIF4E expression |
Oct. 13, 2009 |
| 7601699 |
Production of reprogrammed cells with restored potential |
Oct. 13, 2009 |
| 7601696 |
Oct-1 as an oncoprotein and use of nucleic acid inhibitors of Oct-1 for cancer treatment |
Oct. 13, 2009 |
| 7601501 |
Controlling osteogenesis by inhibition of osteogenic suppressors |
Oct. 13, 2009 |
| 7601494 |
Method of screening candidate compounds for susceptibility to biliary excretion |
Oct. 13, 2009 |
| 7601367 |
Compositions and processes using siRNA, amphipathic compounds and polycations |
Oct. 13, 2009 |
| 7598370 |
siRNA targeting polo-like kinase-1 (PLK-1) |
Oct. 6, 2009 |
| 7598369 |
siRNA targeting histamine receptor H1 |
Oct. 6, 2009 |
| 7595389 |
siRNA targeting casitas B cell lymphoma-B (CBL-B) |
Sep. 29, 2009 |
| 7595388 |
siRNA targeting EPH receptor A3 (EPHA3) |
Sep. 29, 2009 |
| 7595387 |
Modified polynucleotides for reducing off-target effects in RNA interference |
Sep. 29, 2009 |
| 7595386 |
Methods and compositions for heat activated gene therapy using cytolethal distending toxin |
Sep. 29, 2009 |
| 7595306 |
Method of treating neurodegenerative disease |
Sep. 29, 2009 |
| 7595304 |
Polymeric oligonucleotide prodrugs |
Sep. 29, 2009 |
| 7595301 |
Staple type oligonucleotide and drug comprising the same |
Sep. 29, 2009 |
| 7592505 |
UDP-xylose synthases (UXS) polynucleotides, polypeptides, and uses thereof |
Sep. 22, 2009 |
| 7592446 |
Synthesis of selenium-derivatized nucleosides, nucleotides, phosphoramidites, triphosphates and nucleic acids |
Sep. 22, 2009 |
| 7592444 |
siRNA targeting myeloid cell leukemia sequence 1 |
Sep. 22, 2009 |
| 7592443 |
siRNA targeting interleukin-1 receptor-associated kinase 4 (IRAK4) |
Sep. 22, 2009 |
| 7592442 |
siRNA targeting ribonucleotide reductase M2 polypeptide (RRM2 or RNR-R2) |
Sep. 22, 2009 |
| 7592441 |
Liver cancer-related nucleic acids |
Sep. 22, 2009 |
| 7592440 |
Methods of obtaining active antisense compounds |
Sep. 22, 2009 |
| 7592324 |
RNAi-mediated inhibition of ocular targets |
Sep. 22, 2009 |
| 7592323 |
TRPM-2 antisense therapy |
Sep. 22, 2009 |
| 7592322 |
RNAi modulation of RSV, PIV and other respiratory viruses and uses thereof |
Sep. 22, 2009 |
| 7592319 |
Uses of DNA-PK |
Sep. 22, 2009 |
| 7592318 |
88kDa tumorigenic growth factor and antagonists |
Sep. 22, 2009 |
| 7589191 |
siRNA targeting hypoxia-inducible factor 1 |
Sep. 15, 2009 |
| 7589190 |
Potent LNA oligonucleotides for the inhibition of HIF-1A expression |
Sep. 15, 2009 |
| 7589189 |
Inhibition of the expression of huntingtin gene |
Sep. 15, 2009 |
| 7589074 |
Methods and compositions for treatment of inflammatory disease using cadherin-11 modulating agents |
Sep. 15, 2009 |
| 7585969 |
MicroRNA and methods for inhibiting same |
Sep. 8, 2009 |
| 7585968 |
Compositions and their uses directed to thymus and activation-regulated chemokine (TARC) |
Sep. 8, 2009 |
| 7585967 |
Nucleic acid compounds for inhibiting angiogenesis and tumor growth |
Sep. 8, 2009 |
| 7585966 |
Inhibitory polynucleotides directed against the RNA component of telomerase |
Sep. 8, 2009 |
| 7585848 |
Methods and compositions for treating, inhibiting and reversing disorders of the intervertebral disc |
Sep. 8, 2009 |
|
|
|
